PROVENZANO, Michele
 Distribuzione geografica
Continente #
NA - Nord America 438
AS - Asia 338
EU - Europa 163
AF - Africa 5
SA - Sud America 4
OC - Oceania 1
Totale 949
Nazione #
US - Stati Uniti d'America 433
SG - Singapore 210
CN - Cina 103
IT - Italia 78
DE - Germania 23
FI - Finlandia 15
MT - Malta 10
FR - Francia 9
IN - India 8
IE - Irlanda 6
CA - Canada 4
EG - Egitto 4
GB - Regno Unito 4
NL - Olanda 4
RU - Federazione Russa 4
PH - Filippine 3
AT - Austria 2
BR - Brasile 2
EE - Estonia 2
HK - Hong Kong 2
KG - Kirghizistan 2
SA - Arabia Saudita 2
VN - Vietnam 2
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
CL - Cile 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KR - Corea 1
KZ - Kazakistan 1
MY - Malesia 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SE - Svezia 1
Totale 949
Città #
Boardman 341
Singapore 139
Rome 12
Munich 11
Birkirkara 10
Helsinki 9
Chandler 8
Shanghai 8
Jiaxing 7
Dublin 6
Espoo 6
Fort Worth 6
Guangzhou 6
Hyderabad 6
Milan 6
Wuhan 6
Beijing 5
Los Angeles 5
Phoenix 5
Prineville 5
Bari 4
Cosenza 4
Quarto 4
Springfield 4
Trieste 4
Ashburn 3
Bilbeis 3
Bologna 3
Gravina in Puglia 3
New York 3
Nuremberg 3
Toronto 3
Bishkek 2
Buffalo 2
Calcinelli 2
Chicago 2
Crosia 2
Davao City 2
Heze 2
Hong Kong 2
Modena 2
Modugno 2
Pontirolo Nuovo 2
Secaucus 2
Sirmione 2
Tallinn 2
Zhengzhou 2
Almaty 1
Ambrolauri 1
Amsterdam 1
Baku 1
Belcastro 1
Bengaluru 1
Bergamo 1
Bolzano 1
Bremen 1
Brooklyn 1
Brussels 1
Cairo 1
Delhi 1
Florence 1
Guayaquil 1
Hangzhou 1
Ho Chi Minh City 1
Jeddah 1
Jinan 1
Lawrence 1
London 1
Manila 1
Montreal 1
Moscow 1
Nantong 1
Newark 1
Ogden 1
Paris 1
Reggio Calabria 1
Reykjavik 1
Riyadh 1
Roxbury 1
Saarbrücken 1
San José 1
Santa Clara 1
Santiago Metropolitan 1
Seattle 1
Seoul 1
Sioux Falls 1
Slough 1
Sopron 1
Stockholm 1
São Paulo 1
Vienna 1
Washington 1
Wuxi 1
Zibo 1
Totale 725
Nome #
Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease 43
Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials 24
I disegni di studio utilizzati nella ricerca epidemiologica delle malattie croniche 21
[Semaglutide in Chronic Kidney Disease: Great Enthusiasm. But How Does It Work?] 20
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 19
Fabry disease: a rare disorder calling for personalized medicine. 15
Artificial intelligence in chronic kidney diseases: methodology and potential applications 15
Atherosclerotic-nephropathy: an updated narrative review 14
Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience 14
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 14
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 14
Coronary Artery Disease in Patients Undergoing Hemodialysis: A Problem that Sounds the Alarm 13
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 13
[Epidemiology and prognosis of chronic kidney disease in Italy] 13
La gestione dell'iperpotassiemia: nefrologo e cardiologo a confronto [Management of hyperkalemia in Nephrology and Cardiology clinics: reality and perspectives] 13
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 13
Generalizability of DAPA-CKD trial to the real-world setting of outpatient CKD clinics in Italy 12
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD) 12
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 12
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 12
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study 12
[Ultrasonography in chronic lithium nephropathy: a case report] 11
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 11
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 11
Exploring the Level of Post Traumatic Growth in Kidney Transplant Recipients via Network Analysis 11
Role of a dual glucose-dependent insulinotropic peptide (GIP)/glucagon-like peptide-1 receptor agonist (twincretin) in glycemic control: From pathophysiology to treatment 11
Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients 10
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 10
[Role of Ambulatory Blood Pressure Monitoring (ABPM) in chronic kidney patients: a review] 10
Carotid Endarterectomy versus Carotid Artery Stenting With Double-Layer Micromesh Carotid Stent: Contemporary Results of a Single-Center Retrospective Study 10
Precision subclassification of type 2 diabetes: a systematic review 10
Remote patient monitoring in dialysis patients: The "change of pace" for home dialysis | [Monitoraggio da remoto del paziente in dialisi: Il cambio di passo per la dialisi domiciliare?] 10
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses 10
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review 10
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 9
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study 9
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 9
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease 9
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology 9
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 9
Clinical and Pathological Correlations in Chronic Venous Disease 9
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis 9
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization 9
Sodium toxicity in peritoneal dialysis: mechanisms and "solutions" 9
The Shaggy Aorta Syndrome: an updated review 9
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 9
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study 8
Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care 8
Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery 8
Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy 8
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 8
Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review 8
Precision gestational diabetes treatment: a systematic review and meta-analyses 8
Up-Date on Diabetic Nephropathy 8
Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature 8
Ruolo della proteinuria nella ricerca clinica: per ogni vecchia risposta, una nuova domanda [Role of proteinuria in clinical research: for each old-answer, a new key-question.] 8
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease 8
Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease 8
Role of Estimated Glomerular Filtration Rate in Clinical Research: The Never-Ending Matter 8
Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease 8
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine 8
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review 8
Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis 8
Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases 8
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care 8
Central Venous Stenosis after Hemodialysis: Case Reports and Relationships to Catheters and Cardiac Implantable Devices 8
The use of the Amplatzer Vascular Plug in the prevention of endoleaks during abdominal endovascular aneurysm repair: A systematic literature review on current applications 8
Predictive effect of salt intake on patient and kidney survival in non-dialysis CKD: competing risk analysis in older versus younger patients under nephrology care 8
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria 7
Precision Nephrology Is a Non-Negligible State of Mind in Clinical Research: Remember the Past to Face the Future 7
Delirium accompanies kidney dysfunction in hospitalized elderly patients 7
Participant characteristics in the prevention of gestational diabetes as evidence for precision medicine: a systematic review and meta-analysis 7
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients 7
The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists 7
Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies 7
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 7
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease 7
Hyperkalemia in CKD: an overview of available therapeutic strategies 7
Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome 7
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 7
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic 7
Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD 7
Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care 7
Omics in chronic kidney disease: Focus on prognosis and prediction 7
Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile 7
Workplace Violence towards Healthcare Workers: An Italian Cross-Sectional Survey 7
Screening Performance of Edmonton Symptom Assessment System in Kidney Transplant Recipients 7
Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic subjects 6
Precision stratification of prognostic risk factors associated with outcomes in gestational diabetes mellitus: a systematic review 6
Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report 6
Statins in patients with chronic kidney disease: new evidence 6
Sodium Intake and Chronic Kidney Disease 6
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 6
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion 6
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 6
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review 6
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 6
Genotype-stratified treatment for monogenic insulin resistance: a systematic review 6
COVID-19 and diabetes—Two giants colliding: From pathophysiology to management 6
Utility of Blood Flow/Resistance Index Ratio (Q x) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 6
Totale 968
Categoria #
all - tutte 11.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 1 0 0 1 2
2022/202321 4 2 0 1 2 2 0 2 6 0 1 1
2023/2024268 1 0 0 1 2 2 1 1 1 1 141 117
2024/2025970 404 364 91 87 24 0 0 0 0 0 0 0
Totale 1.263